150 related articles for article (PubMed ID: 21631420)
61. An ERBB3/ERBB2 oncogenic unit plays a key role in NRG1 signaling and melanoma cell growth and survival.
Zhang K; Wong P; Duan J; Jacobs B; Borden EC; Bedogni B
Pigment Cell Melanoma Res; 2013 May; 26(3):408-14. PubMed ID: 23480537
[TBL] [Abstract][Full Text] [Related]
62. NRG1-dependent activation of HER3 induces primary resistance to trastuzumab in HER2-overexpressing breast cancer cells.
Yang L; Li Y; Shen E; Cao F; Li L; Li X; Wang X; Kariminia S; Chang B; Li H; Li Q
Int J Oncol; 2017 Nov; 51(5):1553-1562. PubMed ID: 29048656
[TBL] [Abstract][Full Text] [Related]
63. Neuregulin-1β for the treatment of systolic heart failure.
Sawyer DB; Caggiano A
J Mol Cell Cardiol; 2011 Oct; 51(4):501-5. PubMed ID: 21729703
[TBL] [Abstract][Full Text] [Related]
64. Neuregulin-1alpha and beta isoform expression in cardiac microvascular endothelial cells and function in cardiac myocytes in vitro.
Cote GM; Miller TA; Lebrasseur NK; Kuramochi Y; Sawyer DB
Exp Cell Res; 2005 Nov; 311(1):135-46. PubMed ID: 16185687
[TBL] [Abstract][Full Text] [Related]
65. NRG1-ErbB Lost in Translation: A New Paradigm for Lung Cancer?
Trombetta D; Rossi A; Fabrizio FP; Sparaneo A; Graziano P; Fazio VM; Muscarella LA
Curr Med Chem; 2017; 24(38):4213-4228. PubMed ID: 28901268
[TBL] [Abstract][Full Text] [Related]
66. Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells.
Puricelli L; Proietti CJ; Labriola L; Salatino M; Balañá ME; Aguirre Ghiso J; Lupu R; Pignataro OP; Charreau EH; Bal de Kier Joffé E; Elizalde PV
Int J Cancer; 2002 Aug; 100(6):642-53. PubMed ID: 12209601
[TBL] [Abstract][Full Text] [Related]
67. A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure.
Gao R; Zhang J; Cheng L; Wu X; Dong W; Yang X; Li T; Liu X; Xu Y; Li X; Zhou M
J Am Coll Cardiol; 2010 May; 55(18):1907-14. PubMed ID: 20430261
[TBL] [Abstract][Full Text] [Related]
68. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
Ishizawar RC; Miyake T; Parsons SJ
Oncogene; 2007 May; 26(24):3503-10. PubMed ID: 17173075
[TBL] [Abstract][Full Text] [Related]
69. Current and future G protein-coupled receptor signaling targets for heart failure therapy.
Siryk-Bathgate A; Dabul S; Lymperopoulos A
Drug Des Devel Ther; 2013; 7():1209-22. PubMed ID: 24143078
[TBL] [Abstract][Full Text] [Related]
70. A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.
Zhang K; Wong P; Zhang L; Jacobs B; Borden EC; Aster JC; Bedogni B
Oncogene; 2012 Oct; 31(43):4609-18. PubMed ID: 22249266
[TBL] [Abstract][Full Text] [Related]
71. Neuregulin in cardiovascular development and disease.
Odiete O; Hill MF; Sawyer DB
Circ Res; 2012 Oct; 111(10):1376-85. PubMed ID: 23104879
[TBL] [Abstract][Full Text] [Related]
72. Neuregulin signaling and heart failure.
Jiang Z; Zhou M
Curr Heart Fail Rep; 2010 Mar; 7(1):42-7. PubMed ID: 20425496
[TBL] [Abstract][Full Text] [Related]
73. Neuregulin-1/erbB activities with focus on the susceptibility of the heart to anthracyclines.
Vasti C; Hertig CM
World J Cardiol; 2014 Jul; 6(7):653-62. PubMed ID: 25068025
[TBL] [Abstract][Full Text] [Related]
74. Mapping nucleolar and spliceosome localization sequences of neuregulin1-beta3.
Golding M; Ruhrberg C; Sandle J; Gullick WJ
Exp Cell Res; 2004 Sep; 299(1):110-8. PubMed ID: 15302578
[TBL] [Abstract][Full Text] [Related]
75. ERBB2 inhibition and heart failure.
Kühn B
N Engl J Med; 2013 Feb; 368(9):875-6. PubMed ID: 23445110
[No Abstract] [Full Text] [Related]
76. G-Protein-Coupled Receptors in Heart Disease.
Wang J; Gareri C; Rockman HA
Circ Res; 2018 Aug; 123(6):716-735. PubMed ID: 30355236
[TBL] [Abstract][Full Text] [Related]
77. Targeting Neuregulin1 and HER receptor tyrosine kinases for therapy of breast cancer and heart failure.
Yan X
Curr Pharm Des; 2014; 20(30):4854-5. PubMed ID: 24283949
[No Abstract] [Full Text] [Related]
78. The ErbB receptor tyrosine family as signal integrators.
Hynes NE; Horsch K; Olayioye MA; Badache A
Endocr Relat Cancer; 2001 Sep; 8(3):151-9. PubMed ID: 11566606
[TBL] [Abstract][Full Text] [Related]
79. The role of anticytokine therapy in heart failure: recent lessons from preclinical and clinical trials?
Feldman AM; Kadokami T; Higuichi Y; Ramani R; McTiernan CF
Med Clin North Am; 2003 Mar; 87(2):419-40. PubMed ID: 12693732
[TBL] [Abstract][Full Text] [Related]
80. Neuregulin-1, a potential therapeutic target for cardiac repair.
Wang Y; Wei J; Zhang P; Zhang X; Wang Y; Chen W; Zhao Y; Cui X
Front Pharmacol; 2022; 13():945206. PubMed ID: 36120374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
